GERN Q3 2019 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$131,000-20.6% YoY

Gross Profit

-$11M-8380.2% margin

Operating Income

-$16M-12192.4% margin

Net Income

-$15M-11587.8% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+29.7%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$164M

Total Liabilities

$12M

Stockholders' Equity

$152M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$131,000	$165,000	-20.6%
Gross Profit	-$11M	-$2M	-514.0%
Operating Income	-$16M	-$7M	-134.7%
Net Income	-$15M	-$6M	-171.2%